Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

HRMY

Harmony Biosciences Holdings Inc

Oct 04 • 10:39AM ET

34.50

Dollar change -0.27
Percentage change -0.77	%

Healthcare • Biotechnology • USA • NASD

Held by: CALF IJR VTI VB IWM AVUV VXF VBK SYLD IWO

Scroll to Statements

Index	RUT	P/E	17.67	EPS (ttm)	1.95	Insider Own	45.98%	Shs Outstand	56.77M	Perf Week	-11.83%
Market Cap	1.96B	Forward P/E	9.32	EPS next Y	3.70	Insider Trans	-0.14%	Shs Float	30.70M	Perf Month	-2.98%
Income	114.99M	PEG	0.78	EPS next Q	0.68	Inst Own	65.55%	Short Float	27.40%	Perf Quarter	6.03%
Sales	656.11M	P/S	2.99	EPS this Y	5.32%	Inst Trans	4.46%	Short Ratio	20.29	Perf Half Y	12.57%
Book/sh	9.48	P/B	3.64	EPS next Y	65.09%	ROA	14.21%	Short Interest	8.41M	Perf Year	8.56%
Cash/sh	6.10	P/C	5.65	EPS next 5Y	22.60%	ROE	22.46%	52W Range	18.61 - 40.60	Perf YTD	6.82%
Dividend Est.	-	P/FCF	9.21	EPS past 5Y	-	ROI	16.18%	52W High	-15.02%	Beta	0.76
Dividend TTM	-	Quick Ratio	3.09	Sales past 5Y	546.41%	Gross Margin	75.78%	52W Low	85.38%	ATR (14)	1.55
Dividend Ex-Date	-	Current Ratio	3.13	EPS Y/Y TTM	-41.23%	Oper. Margin	27.14%	RSI (14)	38.35	Volatility	5.79% 4.21%
Employees	246	Debt/Eq	0.41	Sales Y/Y TTM	31.52%	Profit Margin	17.53%	Recom	1.88	Target Price	44.88
Option/Short	Yes / Yes	LT Debt/Eq	0.32	EPS Q/Q	-64.34%	Payout	0.00%	Rel Volume	0.52	Prev Close	34.77
Sales Surprise	0.17%	EPS Surprise	11864.71%	Sales Q/Q	28.76%	Earnings	Aug 06 BMO	Avg Volume	414.61K	Price	34.50
SMA20	-9.21%	SMA50	-4.19%	SMA200	6.09%	Trades		Volume	46,686	Change	-0.77%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-10-24	Initiated	UBS	Buy	$56
Jun-21-24	Initiated	Citigroup	Buy	$48
Jan-02-24	Downgrade	BofA Securities	Neutral → Underperform	$30
Sep-25-23	Downgrade	Goldman	Neutral → Sell	$40 → $31
Sep-07-23	Initiated	Berenberg	Buy	$59
Apr-20-23	Initiated	BofA Securities	Neutral	$35
Oct-14-22	Upgrade	Jefferies	Hold → Buy	$57 → $61
Oct-14-22	Upgrade	Janney	Neutral → Buy	$57 → $61
Aug-03-22	Downgrade	Jefferies	Buy → Hold	$57
Jul-13-22	Downgrade	Goldman	Buy → Neutral	$55
Jul-07-22	Initiated	Mizuho	Buy	$64
Apr-14-22	Initiated	Cantor Fitzgerald	Overweight	$63
Dec-01-21	Initiated	Oppenheimer	Outperform	$55
Nov-04-21	Initiated	Raymond James	Outperform	$58
Sep-23-21	Initiated	Needham	Buy	$57
Mar-29-21	Upgrade	Goldman	Neutral → Buy	$41 → $43
Sep-14-20	Initiated	Piper Sandler	Overweight	$61
Sep-14-20	Initiated	Jefferies	Buy	$51
Sep-14-20	Initiated	Goldman	Neutral	$43

Show Previous Ratings

Oct-03-24 11:11AM	Mizuho adds 2 new stocks to its Top Picks list (Investing.com)
Oct-01-24 08:45AM	HARMONY BIOSCIENCES HIGHLIGHTS NEW DATA, ROBUST LATE-STAGE PIPELINE WITH NEAR-TERM VALUE CREATION OPPORTUNITIES AND ITS BOLD NEW VISION AT INVESTOR DAY (PR Newswire)
Sep-29-24 04:43AM	Is Harmony Biosciences Holdings, Inc. (HRMY) the Best Cheap Growth Stock to Buy According to Analysts? (Insider Monkey)
Sep-27-24 05:23AM	Harmony Biosciences (HRMY) Surges 6.7%: Is This an Indication of Further Gains? (Zacks)
Sep-26-24 08:05AM	HARMONY BIOSCIENCES TO HOST FIRST INVESTOR DAY ON OCTOBER 1, 2024 (PR Newswire) +6.70%
09:40AM	Loading…
Sep-25-24 09:40AM	Is Harmony Biosciences (HRMY) Stock Undervalued Right Now? (Zacks)
Sep-24-24 12:00PM	Harmony Biosciences (HRMY) Upgraded to Buy: Here's What You Should Know (Zacks)
Sep-21-24 02:26AM	Harmony Biosciences Holdings, Inc. (HRMY): Short Seller Sentiment is Bearish (Insider Monkey)
Sep-10-24 02:56PM	Neurology-Focused Harmony Biosciences Gains Confidence With Wakix Sales Surge, Strategic Pipeline Expansion, Bullish Analyst Says (Benzinga)
Aug-26-24 09:40AM	Is Harmony Biosciences (HRMY) a Great Value Stock Right Now? (Zacks)
Aug-21-24 08:05AM	HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES (PR Newswire)
Aug-16-24 12:20PM	Surging Earnings Estimates Signal Upside for Harmony Biosciences (HRMY) Stock (Zacks)
Aug-14-24 09:55AM	Can Harmony Biosciences (HRMY) Climb 25.05% to Reach the Level Wall Street Analysts Expect? (Zacks)
Aug-09-24 09:40AM	Should Value Investors Buy Harmony Biosciences (HRMY) Stock? (Zacks)
Aug-06-24 09:15PM	Harmony Biosciences (HRMY) Q2 2024 Earnings Call Transcript (Motley Fool) +6.18%
08:45AM	Loading…
08:45AM	Harmony Biosciences Holdings, Inc. (HRMY) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
07:30AM	Harmony Biosciences Reports Strong Second Quarter 2024 Financial Results and Advances Pitolisant High-Dose Program Toward Expected PDUFA Date in 2028 (GlobeNewswire)
Jul-23-24 08:05AM	HARMONY BIOSCIENCES TO REPORT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 6, 2024 (PR Newswire)
Jul-19-24 09:55AM	Wall Street Analysts See a 32.82% Upside in Harmony Biosciences (HRMY): Can the Stock Really Move This High? (Zacks)
Jul-17-24 09:50AM	Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now? (Zacks)
Jul-09-24 06:00AM	7 Cheap Biotech Stocks With Major Upside Potential (InvestorPlace) +6.24%
Jul-01-24 02:18PM	7 Undervalued Biotech Stocks to Buy for Big-Time Returns (InvestorPlace)
Jun-25-24 08:05AM	HARMONY BIOSCIENCES ACKNOWLEDGES U.S. FOOD & DRUG ADMINISTRATION (FDA) ACTION DENYING THE CITIZEN PETITION FOR WAKIX® (PITOLSIANT) (PR Newswire)
08:05AM	HARMONY BIOSCIENCES ACKNOWLEDGES U.S. FOOD & DRUG ADMINISTRATION (FDA) ACTION DENYING THE CITIZEN PETITION FOR WAKIX (PITOLISANT) (PR Newswire)
Jun-24-24 12:56PM	7 Biotech Stocks to Buy on the Dip: June 2024 (InvestorPlace)
07:00AM	HARMONY BIOSCIENCES RECEIVES U.S. FOOD AND DRUG ADMINISTRATION APPROVAL FOR WAKIX (PITOLISANT) IN PEDIATRIC PATIENTS WITH NARCOLEPSY (PR Newswire)
Jun-05-24 08:05AM	HARMONY BIOSCIENCES PRESENTS POSITIVE DATA FOR PITOLISANT IN THE TREATMENT OF EXCESSIVE DAYTIME SLEEPINESS AND FATIGUE IN MYOTONIC DYSTROPHY TYPE 1 (PR Newswire)
May-28-24 08:05AM	HARMONY BIOSCIENCES TO PARTICIPATE IN GOLDMAN SACHS 45th ANNUAL GLOBAL HEALTHCARE CONFERENCE (PR Newswire)
May-01-24 12:45PM	Looking for a Growth Stock? 3 Reasons Why Harmony Biosciences (HRMY) is a Solid Choice (Zacks)
11:07AM	Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q1 2024 Earnings Call Transcript (Insider Monkey)
05:45PM	Loading…
Apr-30-24 05:45PM	Harmony Biosciences (HRMY) Q1 2024 Earnings Call Transcript (Motley Fool) +5.68%
01:44PM	Harmony Biosciences Expands It CNS-Focused Pipeline With Epilepsy Candidate, Q1 Earnings Beat Street View (Benzinga)
11:54AM	HRMY Stock Earnings: Harmony Biosciences Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
10:54AM	Harmony Biosciences Acquires Epygenix Therapeutics; Shares Rise (MT Newswires)
09:12AM	Harmony Biosciences Exceeds Analyst Revenue Forecasts While Aligning with EPS Projections in Q1 2024 (GuruFocus.com)
07:05AM	Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy (GlobeNewswire)
07:00AM	Harmony Biosciences Acquires Epygenix Therapeutics, Inc., Adding Late-Stage Epilepsy Franchise to Growing Pipeline of Innovative CNS Assets (PR Newswire)
Apr-16-24 08:05AM	HARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON APRIL 30, 2024 (PR Newswire)
Apr-11-24 08:05AM	HARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP AND COMMERCIALIZE TPM-1116, A HIGHLY POTENT AND SELECTIVE ORAL OREXIN-2 RECEPTOR AGONIST (PR Newswire) +6.44%
Apr-03-24 08:05AM	HARMONY BIOSCIENCES INITIATES GLOBAL PHASE 3 REGISTRATIONAL TRIAL (TEMPO STUDY) OF PITOLISANT IN PATIENTS WITH PRADER-WILLI SYNDROME (PR Newswire)
Mar-26-24 08:05AM	HARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCE (PR Newswire)
Mar-19-24 01:26AM	Harmony Biosciences Holdings Inc's Chief Commercial Officer Sells Company Shares (GuruFocus.com)
Mar-08-24 09:38AM	10 Biotech Stocks with Huge Potential (Insider Monkey)
Feb-28-24 08:05AM	HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES (PR Newswire)
Feb-23-24 11:58AM	Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-22-24 11:57PM	Q4 2023 Harmony Biosciences Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
03:30PM	Harmony Biosciences (HRMY) Q4 2023 Earnings Call Transcript (Motley Fool)
08:45AM	Harmony Biosciences Holdings, Inc. (HRMY) Misses Q4 Earnings and Revenue Estimates (Zacks)
08:12AM	Harmony Biosciences Holdings Inc (HRMY) Reports Robust Revenue Growth in Q4 and Full Year 2023 (GuruFocus.com)
07:30AM	Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates (GlobeNewswire)
Feb-21-24 08:05AM	U.S. FOOD AND DRUG ADMINISTRATION GRANTS PRIORITY REVIEW TO HARMONY BIOSCIENCES' APPLICATION FOR WAKIX (PITOLISANT) IN PEDIATRIC NARCOLEPSY (PR Newswire)
Feb-20-24 08:05AM	HARMONY BIOSCIENCES RECEIVES U.S. FOOD AND DRUG ADMINISTRATION ORPHAN DRUG DESIGNATION FOR PITOLISANT IN PRADER-WILLI SYNDROME (PR Newswire)
Feb-12-24 09:28AM	The 3 Most Undervalued Small-Cap Stocks to Buy in February 2024 (InvestorPlace)
Feb-08-24 08:05AM	HARMONY BIOSCIENCES TO REPORT FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS ON FEBRUARY 22, 2024 (PR Newswire) +5.68%
Feb-07-24 12:36PM	The 3 Most Undervalued Russell 2000 Stocks to Buy in February 2024 (InvestorPlace)
Jan-23-24 09:55AM	Wall Street Analysts Believe Harmony Biosciences Holdings, Inc. (HRMY) Could Rally 28.77%: Here's is How to Trade (Zacks)
04:16AM	18 High Growth Low PE Stocks (Insider Monkey)
Jan-12-24 09:55AM	Bears are Losing Control Over Harmony Biosciences Holdings, Inc. (HRMY), Here's Why It's a 'Buy' Now (Zacks)
Jan-08-24 08:05AM	HARMONY BIOSCIENCES PRELIMINARY UNAUDITED FOURTH QUARTER AND FULL YEAR 2023 NET PRODUCT REVENUE INCREASES MORE THAN 30 PERCENT; PROVIDES 2024 NET PRODUCT REVENUE GUIDANCE (PR Newswire)
Jan-05-24 09:55AM	Does Harmony Biosciences Holdings, Inc. (HRMY) Have the Potential to Rally 32.19% as Wall Street Analysts Expect? (Zacks)
Jan-04-24 12:00PM	All You Need to Know About Harmony Biosciences Holdings, Inc. (HRMY) Rating Upgrade to Buy (Zacks)
Jan-03-24 08:05AM	HARMONY BIOSCIENCES TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE (PR Newswire)
Jan-02-24 06:38PM	Why Harmony Biosciences Stock Got Slammed Today (Motley Fool)
Dec-17-23 12:03PM	7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar (InvestorPlace)
Dec-07-23 08:53PM	Russell 2000 Front-Runners: 3 Stocks to Keep an Eye On (InvestorPlace)
08:05AM	HARMONY BIOSCIENCES ANNOUNCES POSITIVE TOPLINE DATA FROM PHASE 2 SIGNAL DETECTION STUDY EVALUATING PITOLISANT IN ADULT PATIENTS WITH MYOTONIC DYSTROPHY TYPE 1 (PR Newswire)
Dec-05-23 01:02PM	16 Most Undervalued Small-Cap Stocks To Buy According To Hedge Funds (Insider Monkey)
08:05AM	HARMONY BIOSCIENCES TO PRESENT RESULTS FROM BEHAVIORAL STUDY IN 22Q11.2 DELETION SYNDROME AT AMERICAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY ANNUAL MEETING (PR Newswire)
Nov-29-23 09:55AM	Wall Street Analysts Predict a 44.38% Upside in Harmony Biosciences Holdings, Inc. (HRMY): Here's What You Should Know (Zacks)
Nov-16-23 08:05AM	HARMONY BIOSCIENCES TO PARTICIPATE IN PIPER SANDLER 35th ANNUAL HEALTHCARE CONFERENCE (PR Newswire)
Nov-15-23 08:05AM	HARMONY BIOSCIENCES RANKED AMONG TOP 25 FASTEST-GROWING COMPANIES IN NORTH AMERICA ON THE 2023 DELOITTE TECHNOLOGY FAST 500 (PR Newswire)
Nov-13-23 09:55AM	How Much Upside is Left in Harmony Biosciences Holdings, Inc. (HRMY)? Wall Street Analysts Think 76.62% (Zacks)
Nov-08-23 09:40AM	Is Harmony Biosciences (HRMY) Stock Undervalued Right Now? (Zacks)
08:05AM	HARMONY BIOSCIENCES APPOINTS PETER ANASTASIOU TO ITS BOARD OF DIRECTORS (PR Newswire)
Nov-06-23 09:50AM	Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-03-23 11:40AM	HRMY vs. REGN: Which Stock Should Value Investors Buy Now? (Zacks) +5.24%
Oct-31-23 06:00PM	Harmony Biosciences (HRMY) Q3 2023 Earnings Call Transcript (Motley Fool) +19.43%
09:38AM	Harmony Biosciences Holdings Inc (HRMY) Reports Q3 2023 Earnings: 37% YoY Increase in Net Revenue (GuruFocus.com)
08:40AM	Harmony Biosciences Holdings, Inc. (HRMY) Lags Q3 Earnings Estimates (Zacks)
07:30AM	Harmony Biosciences Reports Strong Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-26-23 08:05AM	HARMONY BIOSCIENCES SHOWCASES THE NEWEST PATIENTS AT THE HEART AND PROGRESS AT THE HEART AWARD RECIPIENTS (PR Newswire)
Oct-25-23 10:02AM	Exact Sciences (EXAS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Oct-24-23 10:00AM	Earnings Preview: Harmony Biosciences Holdings, Inc. (HRMY) Q3 Earnings Expected to Decline (Zacks)
Oct-20-23 12:08PM	12 Cheap Biotech Stocks Smart Investors Are Piling Into (Insider Monkey) -5.54%
Oct-17-23 08:05AM	HARMONY BIOSCIENCES TO REPORT THIRD QUARTER 2023 FINANCIAL RESULTS ON OCTOBER 31, 2023 (PR Newswire)
Oct-13-23 12:52PM	Why Shares of Harmony Bioscience Are Falling on Friday (Motley Fool) -30.25%
12:11PM	Wells Fargo, JPMorgan Chase rise; Harmony Biosciences, Belden fall, Friday, 10/13/2023 (Associated Press Finance)
08:00AM	HARMONY BIOSCIENCES ANNOUNCES TOPLINE DATA FROM PHASE 3 INTUNE STUDY EVALUATING PITOLISANT IN PATIENTS WITH IDIOPATHIC HYPERSOMNIA (PR Newswire)
Oct-11-23 08:00AM	HARMONY BIOSCIENCES COMPLETES ACQUISITION OF ZYNERBA PHARMACEUTICALS AND EXPANDS PIPELINE (PR Newswire)
Oct-05-23 08:05AM	HARMONY BIOSCIENCES PRESENTS NEW SECONDARY OUTCOME DATA FROM PHASE 2 SIGNAL DETECTION STUDY IN PATIENTS WITH PRADER-WILLI SYNDROME (PR Newswire)
Oct-04-23 09:25AM	2 Magnificent Growth Stocks to Buy Right Now (Motley Fool)
Sep-27-23 08:00AM	HARMONY BIOSCIENCES ANNOUNCES EXTENSION OF TENDER OFFER TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC. (PR Newswire)
Sep-25-23 10:41AM	Short seller petitions FDA to reverse approval of Harmony Biosciences drug (American City Business Journals) -8.68%
02:45AM	Nike downgraded amid US wholesale pressures, China risks: 4 big analyst cuts (Investing.com)
Sep-20-23 08:05AM	HARMONY BIOSCIENCES PRESIDENT & CEO JEFFREY M. DAYNO, M.D., NAMED TO 2023 PHARMAVOICE 100 LIST OF TOP INDUSTRY LEADERS (PR Newswire)
Sep-15-23 09:00AM	This Biotech Stock Pick Is Just Starting to Make Beautiful Music (TheStreet.com)
Sep-13-23 08:05AM	HARMONY BIOSCIENCES TO PARTICIPATE IN 2023 CANTOR GLOBAL HEALTHCARE CONFERENCE (PR Newswire)
Sep-09-23 03:59PM	10 Biotech Stocks with Biggest Upside (Insider Monkey)
Sep-07-23 12:12PM	Harmony Biosciences Holdings Inc (HRMY): A Deep Dive into Its Performance Potential (GuruFocus.com)
08:05AM	HARMONY BIOSCIENCES ANNOUNCES US FOOD & DRUG ADMINISTRATION ORPHAN DRUG DESIGNATION FOR PITOLISANT FOR TREATMENT OF IDIOPATHIC HYPERSOMNIA (PR Newswire)

Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders. Its product, WAKIX, is a molecule with a novel mechanism of action designed to increase histamine signaling in the brain by binding to H3 receptors. The company was founded by Jeffrey S. Aronin on July 25, 2017 and is headquartered in Plymouth Meeting, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
JEFFREY G DIERKS	Officer	Oct 03 '24	Proposed Sale	35.57	14,961	532,163		Oct 03 04:32 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Oct 01 '24	Option Exercise	24.00	400	9,600	400	Oct 02 04:06 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Oct 01 '24	Sale	40.19	400	16,077	0	Oct 02 04:06 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Sep 30 '24	Option Exercise	0.00	60,000	0	60,000	Oct 02 04:05 PM
Kapadia Sandip	CHIEF FINANCIAL OFFICER	Sep 30 '24	Option Exercise	0.00	60,000	0	60,000	Oct 02 04:04 PM
JEFFREY G DIERKS	Officer	Oct 01 '24	Proposed Sale	40.00	21,796	871,840		Oct 01 04:35 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Sep 30 '24	Option Exercise	24.00	35,846	860,304	35,846	Oct 01 04:07 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Sep 30 '24	Sale	40.03	35,846	1,434,951	0	Oct 01 04:07 PM
JEFFREY G DIERKS	Officer	Sep 30 '24	Proposed Sale	39.13	7,175	280,758		Sep 30 04:28 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Sep 27 '24	Option Exercise	24.00	200	4,800	200	Sep 30 04:03 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Sep 27 '24	Sale	40.05	200	8,009	0	Sep 30 04:03 PM
JEFFREY G DIERKS	Officer	Sep 27 '24	Proposed Sale	39.79	28,971	1,152,756		Sep 27 04:24 PM
Kapadia Sandip	CHIEF FINANCIAL OFFICER	Mar 29 '24	Option Exercise	0.00	15,000	0	15,000	Apr 02 04:31 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Mar 15 '24	Option Exercise	8.22	11,979	98,467	11,979	Mar 18 07:24 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Mar 15 '24	Sale	32.00	11,979	383,328	0	Mar 18 07:24 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Mar 08 '24	Option Exercise	8.22	194	1,595	194	Mar 11 05:17 PM
Dierks Jeffrey	CHIEF COMMERCIAL OFFICER	Mar 08 '24	Sale	32.00	194	6,208	0	Mar 11 05:17 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

HRMY

Harmony Biosciences Holdings Inc

Upgrade your FINVIZ experience